Risk of Unprotected Sex Debated in Gilead HIV Pill ReviewRyan Flinn and Shannon Pettypiece
Healthy people can protect themselves from the deadly HIV virus if they take Gilead Sciences Inc.’s Truvada every day. Whether patients will is an issue dividing AIDS advocates as U.S. regulators weigh approving the pill as the first preventative measure against the disease.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.